Literature DB >> 15040924

Fatal intoxication as a consequence of intranasal administration (snorting) or pulmonary inhalation (smoking) of heroin.

I Thiblin1, S Eksborg, A Petersson, A Fugelstad, J Rajs.   

Abstract

In recent years we have noticed an increasing proportion of mortalities resulting from an overdose of heroin that involve routes of administration other than injection. Of 239 cases of fatal heroin intoxication examined at our department during the period 1997-2000, 18 deaths were associated with non-parental administration. Seven of these fatalities were experienced heroin users who had begun to use more sporadically, seven were recreational "party-users", while the remaining four persons had relapsed into heroin use following long periods of abstinence. The median blood morphine concentration of these non-injectors was 0.095 microg/g (range: 0.02-0.67 microg/g), significantly lower than that of the injectors. Concurrent use of alcohol, other illicit drugs and/or pharmaceutical preparations was observed in 17 of the 18 cases. However, there were no statistically significant differences between the victims of heroin intoxication by injection or by other routes with respect to the proportion who had simultaneously consumed alcohol or benzodiazepines. Pathological alterations like lung fibrosis, liver cirrhosis, endocarditis, etc. were not found to play a significant role in any of the 18 mortalities. We conclude that snorting or smoking heroin probably involves a reduced risk of obtaining high blood concentrations of morphine but still constitutes a considerable risk of lethal outcome due to high variability in blood concentrations. Furthermore, decreased tolerance resulting from periods of reduced or sporadic use appears to be an important risk factor in connection with heroin overdosing by snorting or smoking, which indicate that some heroin addicts may inaccurately assume that these routes of administration are safe when resuming their use of heroin after a period of abstinence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040924     DOI: 10.1016/j.forsciint.2003.10.009

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  8 in total

1.  Non-cardiogenic pulmonary edema, rhabdomyolysis and myocardial injury following heroin inhalation: a case report.

Authors:  G Bazoukis; A Spiliopoulou; K Mourouzis; P Grigoropoulou; A Yalouris
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

2.  A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Douglas Y Shapiro; Sandra D Comer
Journal:  Addiction       Date:  2013-03-13       Impact factor: 6.526

Review 3.  [Asthma and heroin use].

Authors:  Michel Underner; Jean Perriot; Gérard Peiffer; Nematollah Jaafari
Journal:  Presse Med       Date:  2017-07-20       Impact factor: 1.228

4.  Heroin-Related Compounds and Metabolic Ratios in Postmortem Samples Using LC-MS-MS.

Authors:  Gerd Jakobsson; Michael T Truver; Sonja A Wrobel; Henrik Gréen; Robert Kronstrand
Journal:  J Anal Toxicol       Date:  2021-03-12       Impact factor: 3.367

5.  Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.

Authors:  Geoff Bardwell; Tamar Austin; Lisa Maher; Jade Boyd
Journal:  Harm Reduct J       Date:  2021-03-07

6.  Post-Mortem Analysis of Heroin Biomarkers, Morphine and Codeine in Stomach Wall Tissue in Heroin-Related Deaths.

Authors:  Ahmed I Al-Asmari; Hassan Alharbi; Torki A Zughaibi
Journal:  Toxics       Date:  2022-08-14

7.  Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation.

Authors:  Rachael Pizzey; Neil Hunt
Journal:  Harm Reduct J       Date:  2008-07-21

8.  Return to Galileo? The Inquisition of the International Narcotic Control Board.

Authors:  Dan Small; Ernest Drucker
Journal:  Harm Reduct J       Date:  2008-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.